BioMaxima Spółka Akcyjna
PL-MF-000039473 · Poland · Lublin
BioMaxima Spółka Akcyjna is registered in the European database on medical devices as a manufacturer, with 1 700 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
Most frequent device types declared: 100 g, 500 g, PS 241.
Devices declared under this manufacturer
- AZTREONAM
- Blood No 2 LAB-AGAR™
- Cetrimide LAB-AGAR™
- Chromogenic Candida LAB-AGAR™
- Columbia LAB-AGAR™ Base
- Kligler Iron LAB-AGAR™
- Legionella CYE LAB-AGAR™ Base
- MacConkey LAB-AGAR™
- Ringer Solution
- Sabouraud Dextrose Broth
- Sodium Selenite Broth
- Sorbitol Broth
Showing 12 of 1 700 declared devices.
Catalogue references include 1-337-K010, BM300, BT 5011.02, BT 6000, E110135 (K), E110718 (B).
European nomenclature codes declared: W0104080502, W0104010101, W0104010306, W0104010206, W0104080501, W0104010405.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 1 700 |
| Country of registration | Poland |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 1 700 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. BioMaxima Spółka Akcyjna was not found in either the U.S. or the Canadian register.